Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Treatments that reduce oxidative stress and fix mitochondrial problems may help heal chronic wounds.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Isotretinoin can cause serious birth defects and needs careful use, especially in pregnant women.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Certain drugs that block specific enzymes can help treat prostate diseases.

Tadalafil and Finasteride may help treat aggressive melanoma.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Bupropion causes more hair loss than other antidepressants, with paroxetine causing the least.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Older patients sticking to their prostate medication saw lasting health benefits.

Urologists should screen for mental health issues before and during finasteride treatment.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Treatments for hair loss vary, but cell-based options may be the future.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

The combination of finasteride, dutasteride, and minoxidil is generally safe for treating male hair loss with minimal side effects.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.